JPH053453B2 - - Google Patents
Info
- Publication number
- JPH053453B2 JPH053453B2 JP59081649A JP8164984A JPH053453B2 JP H053453 B2 JPH053453 B2 JP H053453B2 JP 59081649 A JP59081649 A JP 59081649A JP 8164984 A JP8164984 A JP 8164984A JP H053453 B2 JPH053453 B2 JP H053453B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- lipid peroxide
- vivo
- rosemary
- allspice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000284 extract Substances 0.000 claims description 30
- -1 lipid peroxide Chemical class 0.000 claims description 28
- 238000001727 in vivo Methods 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 12
- 240000008474 Pimenta dioica Species 0.000 claims description 11
- 235000006990 Pimenta dioica Nutrition 0.000 claims description 11
- 239000003112 inhibitor Substances 0.000 claims description 10
- 239000009724 Salvia extract Substances 0.000 claims description 5
- 229940092258 rosemary extract Drugs 0.000 claims description 5
- 235000020748 rosemary extract Nutrition 0.000 claims description 5
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241001529742 Rosmarinus Species 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 241001072909 Salvia Species 0.000 description 6
- 235000017276 Salvia Nutrition 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 231100000234 hepatic damage Toxicity 0.000 description 3
- 230000008818 liver damage Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 201000011461 pre-eclampsia Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 239000002714 Extracts of rosemary Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010037765 Radiation pneumonitis Diseases 0.000 description 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019306 extracts of rosemary Nutrition 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 201000001386 familial hypercholesterolemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001566 pimenta officinalis powder Substances 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59081649A JPS60224629A (ja) | 1984-04-23 | 1984-04-23 | 生体内過酸化脂質生成抑制剤組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59081649A JPS60224629A (ja) | 1984-04-23 | 1984-04-23 | 生体内過酸化脂質生成抑制剤組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60224629A JPS60224629A (ja) | 1985-11-09 |
JPH053453B2 true JPH053453B2 (de) | 1993-01-14 |
Family
ID=13752183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59081649A Granted JPS60224629A (ja) | 1984-04-23 | 1984-04-23 | 生体内過酸化脂質生成抑制剤組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60224629A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010510271A (ja) * | 2006-11-24 | 2010-04-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | ローズマリー抽出物、これらを含有する食品および医薬品組成物、ならびにその使用 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3283274B2 (ja) * | 1991-06-15 | 2002-05-20 | サントリー株式会社 | 新規組成物 |
US5858370A (en) * | 1993-08-20 | 1999-01-12 | Scottish Agricultural College | Beneficial effects of plant volatile oils |
CN1068505C (zh) * | 1994-09-18 | 2001-07-18 | 陕西韩城花椒精厂 | 花椒精及其生产工艺 |
JPH09308402A (ja) * | 1996-05-23 | 1997-12-02 | Pola Chem Ind Inc | 新規ブロードリーフセージ及びそのエッセンスを含有する組成物 |
JPH10195433A (ja) * | 1996-12-27 | 1998-07-28 | Nippon Nouken:Kk | 抗酸化剤 |
US6855349B2 (en) | 1998-12-07 | 2005-02-15 | Kemin Industries, Inc. | Method for simultaneous extraction of essential oils and antioxidants from Labiatae species and the extract products thereof |
US6450935B1 (en) | 2000-10-13 | 2002-09-17 | Kemin Industries, Inc. | Method for removing essential oils and antioxidants from extract products of lamiaceae species using rolled film evaporation |
WO2002062365A1 (fr) * | 2001-02-01 | 2002-08-15 | Meiji Seika Kaisha, Ltd. | Procede de production d'un extrait vegetal de lamiacee contenant des phenols, et utilisation de ce dernier |
KR100478136B1 (ko) * | 2001-10-24 | 2005-03-21 | 주식회사 내츄로바이오텍 | 항산화 활성을 가지는 식물유래 추출물 |
NZ537568A (en) * | 2002-06-24 | 2008-09-26 | Anthony Devasia Joseph | An ayurvedic nutritional preparation |
JP2007045751A (ja) * | 2005-08-10 | 2007-02-22 | Unitika Ltd | 肝機能賦活剤 |
JPWO2014126199A1 (ja) * | 2013-02-18 | 2017-02-02 | アークレイ株式会社 | 酸化タンパク質分解酵素活性増強化剤 |
CN110974730A (zh) * | 2019-09-27 | 2020-04-10 | 中山大学新华学院 | 一种抗氧化的复方肉桂精油及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5673025A (en) * | 1979-11-20 | 1981-06-17 | Osaka Chem Lab | Metabolism exciting agent |
JPS57165400A (en) * | 1981-04-01 | 1982-10-12 | Osaka Chem Lab | Saponin of astragali radix and its separation |
JPS5916830A (ja) * | 1982-07-19 | 1984-01-28 | Osaka Chem Lab | グルコ−ス吸収抑制剤 |
JPS59145547A (ja) * | 1984-01-26 | 1984-08-21 | Denki Kagaku Kogyo Kk | 放熱シ−トの製造法 |
-
1984
- 1984-04-23 JP JP59081649A patent/JPS60224629A/ja active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5673025A (en) * | 1979-11-20 | 1981-06-17 | Osaka Chem Lab | Metabolism exciting agent |
JPS57165400A (en) * | 1981-04-01 | 1982-10-12 | Osaka Chem Lab | Saponin of astragali radix and its separation |
JPS5916830A (ja) * | 1982-07-19 | 1984-01-28 | Osaka Chem Lab | グルコ−ス吸収抑制剤 |
JPS59145547A (ja) * | 1984-01-26 | 1984-08-21 | Denki Kagaku Kogyo Kk | 放熱シ−トの製造法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010510271A (ja) * | 2006-11-24 | 2010-04-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | ローズマリー抽出物、これらを含有する食品および医薬品組成物、ならびにその使用 |
Also Published As
Publication number | Publication date |
---|---|
JPS60224629A (ja) | 1985-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3245654B2 (ja) | コゴメバオトギリソウの安定な抽出物、その調製方法および薬学的組成物 | |
JP4669920B2 (ja) | 血糖上昇抑制且つ血圧上昇抑制作用を有する機能性素材 | |
NO324654B1 (no) | Farmasoytisk sammensetning innbefattende koenzym Q10 | |
JPH053453B2 (de) | ||
NO328797B1 (no) | Anvendelse av essensielle fettsyrer inneholdende en blanding av eikosapentaensyreetylester (EPA) og docosaheksaensyreetylester (DHA) for fremstilling av et medikament nyttig ved forebyggelse av dodsfall hos en pasient som har hatt et hjerteinfarkt. | |
WO2000039249A1 (fr) | Extrait de prune umeboshi a effets medicamenteux et compositions associees | |
KR100399671B1 (ko) | 고혈압증또는이에기인하는의학적증상의예방또는개선제 | |
US7767236B2 (en) | Plant seed extract composition and process for producing the same | |
US6329000B1 (en) | Extract of pine needle and the use thereof | |
JP2008222656A (ja) | 肥満改善および予防用組成物ならびに健康食品 | |
JPH07119176B2 (ja) | 抗活性酸素作用組成物並びにこれを有効成分とする抗活性酸素剤、食品、化粧料及び医薬品 | |
JPH05502457A (ja) | カバーカバ抽出物、これらの製造プロセスおよび使用 | |
EP1368045B1 (de) | Verfahren zur gewinnung von dekokten aus schalen von vitis labrusca und vitis vinifera | |
JPH09262066A (ja) | 高脂血症を抑制するための食品および医薬組成物 | |
JP2012219077A (ja) | 医薬用組成物 | |
WO2006104153A1 (ja) | 血液中の抗酸化活性を高める組成物 | |
EP1495765A1 (de) | Zusammensetzung zur prävention von arteriosklerose | |
JP3142192B2 (ja) | 血中脂質改善剤及びこれを含有する組成物 | |
KR100767051B1 (ko) | 오보바톨 또는 오보바탈의 분리방법과 이를 유효성분으로함유하는 비만치료 및 예방용 조성물 및 상기 유효성분의정제방법 | |
US7357951B2 (en) | Composition for preventing atherosclerosis | |
JP2001139945A (ja) | 抗酸化剤 | |
KR100504966B1 (ko) | 진세노사이드 Rg3 및 Rh2를 함유함을 특징으로 하는 항고혈압 조성물 | |
JPS63295512A (ja) | 制ガン剤 | |
JPS59175425A (ja) | 脳卒中予防剤 | |
JP3936245B2 (ja) | 血圧降下剤 |